1 Study Coverage 1.1 Risperidone Product Introduction 1.2 Global Risperidone Outlook 2017 VS 2022 VS 2028 1.2.1 Global Risperidone Sales in US$ Million for the Year 2017-2028 1.2.2 Global Risperidone Sales in Volume for the Year 2017-2028 1.3 United States Risperidone Outlook 2017 VS 2022 VS 2028 1.3.1 United States Risperidone Sales in US$ Million for the Year 2017-2028 1.3.2 United States Risperidone Sales in Volume for the Year 2017-2028 1.4 Risperidone Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Risperidone in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Risperidone Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Risperidone Market Dynamics 1.5.1 Risperidone Industry Trends 1.5.2 Risperidone Market Drivers 1.5.3 Risperidone Market Challenges 1.5.4 Risperidone Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Risperidone Market Segment by Type 2.1.1 Oral 2.1.2 Injectable 2.2 Global Risperidone Market Size by Type 2.2.1 Global Risperidone Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Risperidone Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Risperidone Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Risperidone Market Size by Type 2.3.1 United States Risperidone Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Risperidone Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Risperidone Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Risperidone Market Segment by Application 3.1.1 Schizophrenia 3.1.2 Bipolar Disorder 3.2 Global Risperidone Market Size by Application 3.2.1 Global Risperidone Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Risperidone Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Risperidone Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Risperidone Market Size by Application 3.3.1 United States Risperidone Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Risperidone Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Risperidone Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Risperidone Competitor Landscape by Company 4.1 Global Risperidone Market Size by Company 4.1.1 Top Global Risperidone Manufacturers Ranked by Revenue (2021) 4.1.2 Global Risperidone Revenue by Manufacturer (2017-2022) 4.1.3 Global Risperidone Sales by Manufacturer (2017-2022) 4.1.4 Global Risperidone Price by Manufacturer (2017-2022) 4.2 Global Risperidone Concentration Ratio (CR) 4.2.1 Risperidone Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Risperidone in 2021 4.2.3 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Risperidone Manufacturing Base Distribution, Product Type 4.3.1 Global Risperidone Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Risperidone Product Type 4.3.3 Date of International Manufacturers Enter into Risperidone Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Risperidone Market Size by Company 4.5.1 Top Risperidone Players in United States, Ranked by Revenue (2021) 4.5.2 United States Risperidone Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Risperidone Sales by Players (2020, 2021 & 2022) 5 Global Risperidone Market Size by Region 5.1 Global Risperidone Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Risperidone Market Size in Volume by Region (2017-2028) 5.2.1 Global Risperidone Sales in Volume by Region: 2017-2022 5.2.2 Global Risperidone Sales in Volume Forecast by Region (2023-2028) 5.3 Global Risperidone Market Size in Value by Region (2017-2028) 5.3.1 Global Risperidone Sales in Value by Region: 2017-2022 5.3.2 Global Risperidone Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Risperidone Market Size YoY Growth 2017-2028 6.1.2 North America Risperidone Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Risperidone Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Risperidone Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Risperidone Market Size YoY Growth 2017-2028 6.3.2 Europe Risperidone Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Risperidone Market Size YoY Growth 2017-2028 6.4.2 Latin America Risperidone Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Risperidone Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Risperidone Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Janssen Pharmaceutica 7.1.1 Janssen Pharmaceutica Corporation Information 7.1.2 Janssen Pharmaceutica Description and Business Overview 7.1.3 Janssen Pharmaceutica Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Janssen Pharmaceutica Risperidone Products Offered 7.1.5 Janssen Pharmaceutica Recent Development 7.2 Teva 7.2.1 Teva Corporation Information 7.2.2 Teva Description and Business Overview 7.2.3 Teva Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Teva Risperidone Products Offered 7.2.5 Teva Recent Development 7.3 Sun Pharmaceutical 7.3.1 Sun Pharmaceutical Corporation Information 7.3.2 Sun Pharmaceutical Description and Business Overview 7.3.3 Sun Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Sun Pharmaceutical Risperidone Products Offered 7.3.5 Sun Pharmaceutical Recent Development 7.4 Aurobindo 7.4.1 Aurobindo Corporation Information 7.4.2 Aurobindo Description and Business Overview 7.4.3 Aurobindo Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Aurobindo Risperidone Products Offered 7.4.5 Aurobindo Recent Development 7.5 Cipla 7.5.1 Cipla Corporation Information 7.5.2 Cipla Description and Business Overview 7.5.3 Cipla Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Cipla Risperidone Products Offered 7.5.5 Cipla Recent Development 7.6 Invent Farma Group 7.6.1 Invent Farma Group Corporation Information 7.6.2 Invent Farma Group Description and Business Overview 7.6.3 Invent Farma Group Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Invent Farma Group Risperidone Products Offered 7.6.5 Invent Farma Group Recent Development 7.7 Medichem 7.7.1 Medichem Corporation Information 7.7.2 Medichem Description and Business Overview 7.7.3 Medichem Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Medichem Risperidone Products Offered 7.7.5 Medichem Recent Development 7.8 Interquim 7.8.1 Interquim Corporation Information 7.8.2 Interquim Description and Business Overview 7.8.3 Interquim Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Interquim Risperidone Products Offered 7.8.5 Interquim Recent Development 7.9 IPCA 7.9.1 IPCA Corporation Information 7.9.2 IPCA Description and Business Overview 7.9.3 IPCA Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.9.4 IPCA Risperidone Products Offered 7.9.5 IPCA Recent Development 7.10 RPG 7.10.1 RPG Corporation Information 7.10.2 RPG Description and Business Overview 7.10.3 RPG Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.10.4 RPG Risperidone Products Offered 7.10.5 RPG Recent Development 7.11 Sharon 7.11.1 Sharon Corporation Information 7.11.2 Sharon Description and Business Overview 7.11.3 Sharon Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Sharon Risperidone Products Offered 7.11.5 Sharon Recent Development 7.12 Torrent Pharmaceuticals 7.12.1 Torrent Pharmaceuticals Corporation Information 7.12.2 Torrent Pharmaceuticals Description and Business Overview 7.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Torrent Pharmaceuticals Products Offered 7.12.5 Torrent Pharmaceuticals Recent Development 7.13 Temad 7.13.1 Temad Corporation Information 7.13.2 Temad Description and Business Overview 7.13.3 Temad Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Temad Products Offered 7.13.5 Temad Recent Development 7.14 Wuxi Jida 7.14.1 Wuxi Jida Corporation Information 7.14.2 Wuxi Jida Description and Business Overview 7.14.3 Wuxi Jida Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Wuxi Jida Products Offered 7.14.5 Wuxi Jida Recent Development 7.15 Changzhou Siyao Pharmaceuticals 7.15.1 Changzhou Siyao Pharmaceuticals Corporation Information 7.15.2 Changzhou Siyao Pharmaceuticals Description and Business Overview 7.15.3 Changzhou Siyao Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Changzhou Siyao Pharmaceuticals Products Offered 7.15.5 Changzhou Siyao Pharmaceuticals Recent Development 7.16 Ningbo Team Pharm 7.16.1 Ningbo Team Pharm Corporation Information 7.16.2 Ningbo Team Pharm Description and Business Overview 7.16.3 Ningbo Team Pharm Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.16.4 Ningbo Team Pharm Products Offered 7.16.5 Ningbo Team Pharm Recent Development 7.17 Zhejiang Huahai Pharmaceutical 7.17.1 Zhejiang Huahai Pharmaceutical Corporation Information 7.17.2 Zhejiang Huahai Pharmaceutical Description and Business Overview 7.17.3 Zhejiang Huahai Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.17.4 Zhejiang Huahai Pharmaceutical Products Offered 7.17.5 Zhejiang Huahai Pharmaceutical Recent Development 7.18 TIPR 7.18.1 TIPR Corporation Information 7.18.2 TIPR Description and Business Overview 7.18.3 TIPR Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.18.4 TIPR Products Offered 7.18.5 TIPR Recent Development 7.19 Qilu Pharmaceutical 7.19.1 Qilu Pharmaceutical Corporation Information 7.19.2 Qilu Pharmaceutical Description and Business Overview 7.19.3 Qilu Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2017-2022) 7.19.4 Qilu Pharmaceutical Products Offered 7.19.5 Qilu Pharmaceutical Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Risperidone Industry Chain Analysis 8.2 Risperidone Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Risperidone Distributors 8.3 Risperidone Production Mode & Process 8.4 Risperidone Sales and Marketing 8.4.1 Risperidone Sales Channels 8.4.2 Risperidone Distributors 8.5 Risperidone Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Risperidone CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Risperidone Market Trends Table 3. Risperidone Market Drivers Table 4. Risperidone Market Challenges Table 5. Risperidone Market Restraints Table 6. Global Risperidone Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Risperidone Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Risperidone Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Risperidone Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Risperidone Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Risperidone Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Risperidone Revenue Share by Manufacturer, 2017-2022 Table 13. Global Risperidone Sales by Manufacturer, (K Pcs), 2017-2022 Table 14. Global Risperidone Sales Share by Manufacturer, 2017-2022 Table 15. Global Risperidone Price by Manufacturer (2017-2022) & (USD/Pcs) Table 16. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2021) Table 18. Top Players of Risperidone in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Risperidone Product Type Table 20. Date of International Manufacturers Enter into Risperidone Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Risperidone Players in United States Market, Ranking by Revenue (2021) Table 23. United States Risperidone Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Risperidone Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Risperidone Sales by Players, (K Pcs), 2020, 2021 & 2022 Table 26. United States Risperidone Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Risperidone Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Risperidone Sales in Volume by Region (2017-2022) & (K Pcs) Table 29. Global Risperidone Sales in Volume Forecast by Region (2023-2028) & (K Pcs) Table 30. Global Risperidone Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Risperidone Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Risperidone Sales in Volume by Country (2017-2028) & (K Pcs) Table 33. North America Risperidone Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Risperidone Sales in Volume by Region (2017-2028) & (K Pcs) Table 35. Asia Pacific Risperidone Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Risperidone Sales in Volume by Country (2017-2028) & (K Pcs) Table 37. Europe Risperidone Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Risperidone Sales in Volume by Country (2017-2028) & (K Pcs) Table 39. Latin Americaa Risperidone Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Risperidone Sales in Volume by Country (2017-2028) & (K Pcs) Table 41. Middle East and Africa Risperidone Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Janssen Pharmaceutica Corporation Information Table 43. Janssen Pharmaceutica Description and Business Overview Table 44. Janssen Pharmaceutica Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 45. Janssen Pharmaceutica Risperidone Product Table 46. Janssen Pharmaceutica Recent Development Table 47. Teva Corporation Information Table 48. Teva Description and Business Overview Table 49. Teva Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 50. Teva Product Table 51. Teva Recent Development Table 52. Sun Pharmaceutical Corporation Information Table 53. Sun Pharmaceutical Description and Business Overview Table 54. Sun Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 55. Sun Pharmaceutical Product Table 56. Sun Pharmaceutical Recent Development Table 57. Aurobindo Corporation Information Table 58. Aurobindo Description and Business Overview Table 59. Aurobindo Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 60. Aurobindo Product Table 61. Aurobindo Recent Development Table 62. Cipla Corporation Information Table 63. Cipla Description and Business Overview Table 64. Cipla Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 65. Cipla Product Table 66. Cipla Recent Development Table 67. Invent Farma Group Corporation Information Table 68. Invent Farma Group Description and Business Overview Table 69. Invent Farma Group Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 70. Invent Farma Group Product Table 71. Invent Farma Group Recent Development Table 72. Medichem Corporation Information Table 73. Medichem Description and Business Overview Table 74. Medichem Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 75. Medichem Product Table 76. Medichem Recent Development Table 77. Interquim Corporation Information Table 78. Interquim Description and Business Overview Table 79. Interquim Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 80. Interquim Product Table 81. Interquim Recent Development Table 82. IPCA Corporation Information Table 83. IPCA Description and Business Overview Table 84. IPCA Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 85. IPCA Product Table 86. IPCA Recent Development Table 87. RPG Corporation Information Table 88. RPG Description and Business Overview Table 89. RPG Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 90. RPG Product Table 91. RPG Recent Development Table 92. Sharon Corporation Information Table 93. Sharon Description and Business Overview Table 94. Sharon Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 95. Sharon Product Table 96. Sharon Recent Development Table 97. Torrent Pharmaceuticals Corporation Information Table 98. Torrent Pharmaceuticals Description and Business Overview Table 99. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 100. Torrent Pharmaceuticals Product Table 101. Torrent Pharmaceuticals Recent Development Table 102. Temad Corporation Information Table 103. Temad Description and Business Overview Table 104. Temad Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 105. Temad Product Table 106. Temad Recent Development Table 107. Wuxi Jida Corporation Information Table 108. Wuxi Jida Description and Business Overview Table 109. Wuxi Jida Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 110. Wuxi Jida Product Table 111. Wuxi Jida Recent Development Table 112. Changzhou Siyao Pharmaceuticals Corporation Information Table 113. Changzhou Siyao Pharmaceuticals Description and Business Overview Table 114. Changzhou Siyao Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 115. Changzhou Siyao Pharmaceuticals Product Table 116. Changzhou Siyao Pharmaceuticals Recent Development Table 117. Ningbo Team Pharm Corporation Information Table 118. Ningbo Team Pharm Description and Business Overview Table 119. Ningbo Team Pharm Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 120. Ningbo Team Pharm Product Table 121. Ningbo Team Pharm Recent Development Table 122. Zhejiang Huahai Pharmaceutical Corporation Information Table 123. Zhejiang Huahai Pharmaceutical Description and Business Overview Table 124. Zhejiang Huahai Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 125. Zhejiang Huahai Pharmaceutical Product Table 126. Zhejiang Huahai Pharmaceutical Recent Development Table 127. TIPR Corporation Information Table 128. TIPR Description and Business Overview Table 129. TIPR Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 130. TIPR Product Table 131. TIPR Recent Development Table 132. Qilu Pharmaceutical Corporation Information Table 133. Qilu Pharmaceutical Description and Business Overview Table 134. Qilu Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 135. Qilu Pharmaceutical Product Table 136. Qilu Pharmaceutical Recent Development Table 137. Key Raw Materials Lists Table 138. Raw Materials Key Suppliers Lists Table 139. Risperidone Customers List Table 140. Risperidone Distributors List Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Risperidone Product Picture Figure 2. Global Risperidone Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Risperidone Market Size 2017-2028 (US$ Million) Figure 4. Global Risperidone Sales 2017-2028 (K Pcs) Figure 5. United States Risperidone Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Risperidone Market Size 2017-2028 (US$ Million) Figure 7. United States Risperidone Sales 2017-2028 (K Pcs) Figure 8. United States Risperidone Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Risperidone Market Share in Global, in Volume (K Pcs) 2017-2028 Figure 10. Risperidone Report Years Considered Figure 11. Product Picture of Oral Figure 12. Product Picture of Injectable Figure 13. Global Risperidone Market Share by Type in 2022 & 2028 Figure 14. Global Risperidone Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Risperidone Sales Market Share in Value by Type (2017-2028) Figure 16. Global Risperidone Sales by Type (2017-2028) & (K Pcs) Figure 17. Global Risperidone Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Risperidone Price by Type (2017-2028) & (USD/Pcs) Figure 19. United States Risperidone Market Share by Type in 2022 & 2028 Figure 20. United States Risperidone Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Risperidone Sales Market Share in Value by Type (2017-2028) Figure 22. United States Risperidone Sales by Type (2017-2028) & (K Pcs) Figure 23. United States Risperidone Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Risperidone Price by Type (2017-2028) & (USD/Pcs) Figure 25. Product Picture of Schizophrenia Figure 26. Product Picture of Bipolar Disorder Figure 27. Global Risperidone Market Share by Application in 2022 & 2028 Figure 28. Global Risperidone Sales in Value by Application (2017-2028) & (US$ Million) Figure 29. Global Risperidone Sales Market Share in Value by Application (2017-2028) Figure 30. Global Risperidone Sales by Application (2017-2028) & (K Pcs) Figure 31. Global Risperidone Sales Market Share in Volume by Application (2017-2028) Figure 32. Global Risperidone Price by Application (2017-2028) & (USD/Pcs) Figure 33. United States Risperidone Market Share by Application in 2022 & 2028 Figure 34. United States Risperidone Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. United States Risperidone Sales Market Share in Value by Application (2017-2028) Figure 36. United States Risperidone Sales by Application (2017-2028) & (K Pcs) Figure 37. United States Risperidone Sales Market Share in Volume by Application (2017-2028) Figure 38. United States Risperidone Price by Application (2017-2028) & (USD/Pcs) Figure 39. North America Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 40. North America Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 41. U.S. Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 42. Canada Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Europe Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 44. Europe Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 45. Germany Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. France Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. U.K. Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Italy Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Russia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Asia-Pacific Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 51. Asia-Pacific Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 52. China Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Japan Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. South Korea Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. India Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Australia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. China Taiwan Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Indonesia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Thailand Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Malaysia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Latin America Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 62. Latin America Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 63. Mexico Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Brazil Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Argentina Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Middle East & Africa Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 67. Middle East & Africa Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 68. Turkey Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Saudi Arabia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. UAE Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Risperidone Value Chain Figure 72. Risperidone Production Process Figure 73. Channels of Distribution Figure 74. Distributors Profiles Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

Janssen Pharmaceutica Teva Sun Pharmaceutical Aurobindo Cipla Invent Farma Group Medichem Interquim IPCA RPG Sharon Torrent Pharmaceuticals Temad Wuxi Jida Changzhou Siyao Pharmaceuticals Ningbo Team Pharm Zhejiang Huahai Pharmaceutical TIPR Qilu Pharmaceutical